PAPER Leitão R, Guerreiro C, Nunes RG, Gonçalves N, Galati G, Rosário M, Guedes LC, Ferreira JJ, Reimão S
SEARCH RESULTS
314 RESULTS
PAPER Singleton AB, Gasser T
The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease.
Mov Disord. 2020 Apr;35(4):551-554. Epub 2020 Feb 17 PubMed: 32065426PAPER Ghanta MK, Elango P, Bhaskar L V K S
Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson's Disease.
Curr Pharm Des. 2020 Feb 16; PubMed: 32065086PAPER Lu Y, Sugawara Y, Zhang S, Tomata Y, Tsuji I
Smoking cessation and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study.
Eur J Epidemiol. 2020 Feb 15; PubMed: 32060675PAPER Flower MD, Tabrizi SJ
A small molecule kicks repeat expansion into reverse.
Nat Genet. 2020 Feb;52(2):136-137. PubMed: 32060488PAPER Lee JJ, Andreazza S, Whitworth AJ
The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models.
Sci Rep. 2020 Feb 14;10(1):2693. PubMed: 32060339PAPER Hamad N, Mashima T, Yamaoki Y, Kondo K, Yoneda R, Oyoshi T, Kurokawa R, Nagata T, Katahira M
RNA sequence and length contribute to RNA-induced conformational change of TLS/FUS.
Sci Rep. 2020 Feb 14;10(1):2629. PubMed: 32060318PAPER Picca A, Guerra F, Calvani R, Marini F, Biancolillo A, Landi G, Beli R, Landi F, Bernabei R, Bentivoglio AR, Monaco MR, Bucci C, Marzetti E
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study.
J Clin Med. 2020 Feb 12;9(2) PubMed: 32059608PAPER de Aguiar V, Zhao Y, Faria A, Ficek B, Webster KT, Wendt H, Wang Z, Hillis AE, Onyike CU, Frangakis C, Caffo B, Tsapkini K
Brain volumes as predictors of tDCS effects in primary progressive aphasia.
Brain Lang. 2020 Jan;200:104707. Epub 2019 Nov 5 PubMed: 31704518PAPER Zhao XJ, Niu XY, You HY, Zhou M, Ji XB, Liu Y, Wu L, Ding XL
Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.
Curr Med Sci. 2019 Oct;39(5):831-835. Epub 2019 Oct 14 PubMed: 31612404PAPER van den Maagdenberg AM, Weng W, de Bruijn IH, de Knijff P, Funke H, Smelt AH, Gevers Leuven JA, van't Hooft FM, Assmann G, Hofker MH
Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.
Am J Hum Genet. 1993 May;52(5):937-46. PubMed: 8488843PAPER Zhao SP, Van den Maagdenberg AM, Vroom TF, Van 't Hooft FM, Gevers Leuvens JA, Havekes LM, Frants RR, Van der Laarse A, Smelt AH
Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia.
Clin Sci (Lond). 1994 Mar;86(3):323-9. PubMed: 8156744PAPER Radwan ZH, Wang X, Waqar F, Pirim D, Niemsiri V, Hokanson JE, Hamman RF, Bunker CH, Barmada MM, Demirci FY, Kamboh MI
Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks.
PLoS One. 2014;9(12):e114618. Epub 2014 Dec 12 PubMed: 25502880PAPER Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW
Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
Proc Natl Acad Sci U S A. 1982 Aug;79(15):4696-700. PubMed: 6289314PAPER Weisgraber KH, Innerarity TL, Mahley RW
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
J Biol Chem. 1982 Mar 10;257(5):2518-21. PubMed: 6277903Current Filters
- Date Range : Feb 2020 to Feb 2020 x